Request for Covid-19 Impact Assessment of this Report
The United States Pharmaceutical Marijuana (MMJ) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmaceutical Marijuana (MMJ) market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Marijuana (MMJ) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pharmaceutical Marijuana (MMJ) players cover Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., and Aphria, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Marijuana (MMJ) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
THC-dominant
CBD-dominant
Balanced THC & CBD
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cancer
Arthritis
Migraine
Epilepsy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Marijuana (MMJ) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pharmaceutical Marijuana (MMJ) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pharmaceutical Marijuana (MMJ) by Country/Region, 2017, 2022 & 2028
2.2 Pharmaceutical Marijuana (MMJ) Segment by Type
2.2.1 THC-dominant
2.2.2 CBD-dominant
2.2.3 Balanced THC & CBD
2.3 Pharmaceutical Marijuana (MMJ) Sales by Type
2.3.1 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2017-2022)
2.3.2 Global Pharmaceutical Marijuana (MMJ) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pharmaceutical Marijuana (MMJ) Sale Price by Type (2017-2022)
2.4 Pharmaceutical Marijuana (MMJ) Segment by Application
2.4.1 Cancer
2.4.2 Arthritis
2.4.3 Migraine
2.4.4 Epilepsy
2.4.5 Others
2.5 Pharmaceutical Marijuana (MMJ) Sales by Application
2.5.1 Global Pharmaceutical Marijuana (MMJ) Sale Market Share by Application (2017-2022)
2.5.2 Global Pharmaceutical Marijuana (MMJ) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pharmaceutical Marijuana (MMJ) Sale Price by Application (2017-2022)
3 Global Pharmaceutical Marijuana (MMJ) by Company
3.1 Global Pharmaceutical Marijuana (MMJ) Breakdown Data by Company
3.1.1 Global Pharmaceutical Marijuana (MMJ) Annual Sales by Company (2020-2022)
3.1.2 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Company (2020-2022)
3.2 Global Pharmaceutical Marijuana (MMJ) Annual Revenue by Company (2020-2022)
3.2.1 Global Pharmaceutical Marijuana (MMJ) Revenue by Company (2020-2022)
3.2.2 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Company (2020-2022)
3.3 Global Pharmaceutical Marijuana (MMJ) Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Marijuana (MMJ) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Marijuana (MMJ) Product Location Distribution
3.4.2 Players Pharmaceutical Marijuana (MMJ) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Marijuana (MMJ) by Geographic Region
4.1 World Historic Pharmaceutical Marijuana (MMJ) Market Size by Geographic Region (2017-2022)
4.1.1 Global Pharmaceutical Marijuana (MMJ) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pharmaceutical Marijuana (MMJ) Annual Revenue by Geographic Region
4.2 World Historic Pharmaceutical Marijuana (MMJ) Market Size by Country/Region (2017-2022)
4.2.1 Global Pharmaceutical Marijuana (MMJ) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pharmaceutical Marijuana (MMJ) Annual Revenue by Country/Region
4.3 Americas Pharmaceutical Marijuana (MMJ) Sales Growth
4.4 APAC Pharmaceutical Marijuana (MMJ) Sales Growth
4.5 Europe Pharmaceutical Marijuana (MMJ) Sales Growth
4.6 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Growth
5 Americas
5.1 Americas Pharmaceutical Marijuana (MMJ) Sales by Country
5.1.1 Americas Pharmaceutical Marijuana (MMJ) Sales by Country (2017-2022)
5.1.2 Americas Pharmaceutical Marijuana (MMJ) Revenue by Country (2017-2022)
5.2 Americas Pharmaceutical Marijuana (MMJ) Sales by Type
5.3 Americas Pharmaceutical Marijuana (MMJ) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Marijuana (MMJ) Sales by Region
6.1.1 APAC Pharmaceutical Marijuana (MMJ) Sales by Region (2017-2022)
6.1.2 APAC Pharmaceutical Marijuana (MMJ) Revenue by Region (2017-2022)
6.2 APAC Pharmaceutical Marijuana (MMJ) Sales by Type
6.3 APAC Pharmaceutical Marijuana (MMJ) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Marijuana (MMJ) by Country
7.1.1 Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2017-2022)
7.1.2 Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2017-2022)
7.2 Europe Pharmaceutical Marijuana (MMJ) Sales by Type
7.3 Europe Pharmaceutical Marijuana (MMJ) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Marijuana (MMJ) by Country
8.1.1 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2017-2022)
8.2 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Type
8.3 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Marijuana (MMJ)
10.3 Manufacturing Process Analysis of Pharmaceutical Marijuana (MMJ)
10.4 Industry Chain Structure of Pharmaceutical Marijuana (MMJ)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Marijuana (MMJ) Distributors
11.3 Pharmaceutical Marijuana (MMJ) Customer
12 World Forecast Review for Pharmaceutical Marijuana (MMJ) by Geographic Region
12.1 Global Pharmaceutical Marijuana (MMJ) Market Size Forecast by Region
12.1.1 Global Pharmaceutical Marijuana (MMJ) Forecast by Region (2023-2028)
12.1.2 Global Pharmaceutical Marijuana (MMJ) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Marijuana (MMJ) Forecast by Type
12.7 Global Pharmaceutical Marijuana (MMJ) Forecast by Application
13 Key Players Analysis
13.1 Canopy Growth Corporation
13.1.1 Canopy Growth Corporation Company Information
13.1.2 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product Offered
13.1.3 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Canopy Growth Corporation Main Business Overview
13.1.5 Canopy Growth Corporation Latest Developments
13.2 GW Pharmaceuticals, plc
13.2.1 GW Pharmaceuticals, plc Company Information
13.2.2 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product Offered
13.2.3 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GW Pharmaceuticals, plc Main Business Overview
13.2.5 GW Pharmaceuticals, plc Latest Developments
13.3 Aurora Cannabis, Inc.
13.3.1 Aurora Cannabis, Inc. Company Information
13.3.2 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
13.3.3 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Aurora Cannabis, Inc. Main Business Overview
13.3.5 Aurora Cannabis, Inc. Latest Developments
13.4 Aphria, Inc.
13.4.1 Aphria, Inc. Company Information
13.4.2 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
13.4.3 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Aphria, Inc. Main Business Overview
13.4.5 Aphria, Inc. Latest Developments
13.5 MedReleaf Corporation
13.5.1 MedReleaf Corporation Company Information
13.5.2 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product Offered
13.5.3 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MedReleaf Corporation Main Business Overview
13.5.5 MedReleaf Corporation Latest Developments
13.6 Insys Therapeutics, Inc.
13.6.1 Insys Therapeutics, Inc. Company Information
13.6.2 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
13.6.3 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Insys Therapeutics, Inc. Main Business Overview
13.6.5 Insys Therapeutics, Inc. Latest Developments
13.7 CanniMed Therapeutics, Inc.
13.7.1 CanniMed Therapeutics, Inc. Company Information
13.7.2 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
13.7.3 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CanniMed Therapeutics, Inc. Main Business Overview
13.7.5 CanniMed Therapeutics, Inc. Latest Developments
13.8 Cara Therapeutics, Inc.
13.8.1 Cara Therapeutics, Inc. Company Information
13.8.2 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
13.8.3 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Cara Therapeutics, Inc. Main Business Overview
13.8.5 Cara Therapeutics, Inc. Latest Developments
13.9 United Cannabis Corporation
13.9.1 United Cannabis Corporation Company Information
13.9.2 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product Offered
13.9.3 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 United Cannabis Corporation Main Business Overview
13.9.5 United Cannabis Corporation Latest Developments
14 Research Findings and Conclusion
Table 1. Pharmaceutical Marijuana (MMJ) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pharmaceutical Marijuana (MMJ) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of THC-dominant
Table 4. Major Players of CBD-dominant
Table 5. Major Players of Balanced THC & CBD
Table 6. Global Pharmaceutical Marijuana (MMJ) Sales by Type (2017-2022) & (K Units)
Table 7. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2017-2022)
Table 8. Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2017-2022) & ($ million)
Table 9. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2017-2022)
Table 10. Global Pharmaceutical Marijuana (MMJ) Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Pharmaceutical Marijuana (MMJ) Sales by Application (2017-2022) & (K Units)
Table 12. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2017-2022)
Table 13. Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2017-2022)
Table 14. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2017-2022)
Table 15. Global Pharmaceutical Marijuana (MMJ) Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Pharmaceutical Marijuana (MMJ) Sales by Company (2020-2022) & (K Units)
Table 17. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Company (2020-2022)
Table 18. Global Pharmaceutical Marijuana (MMJ) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Company (2020-2022)
Table 20. Global Pharmaceutical Marijuana (MMJ) Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Pharmaceutical Marijuana (MMJ) Producing Area Distribution and Sales Area
Table 22. Players Pharmaceutical Marijuana (MMJ) Products Offered
Table 23. Pharmaceutical Marijuana (MMJ) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pharmaceutical Marijuana (MMJ) Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Pharmaceutical Marijuana (MMJ) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Pharmaceutical Marijuana (MMJ) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Pharmaceutical Marijuana (MMJ) Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Pharmaceutical Marijuana (MMJ) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Pharmaceutical Marijuana (MMJ) Sales by Country (2017-2022) & (K Units)
Table 35. Americas Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2017-2022)
Table 36. Americas Pharmaceutical Marijuana (MMJ) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2017-2022)
Table 38. Americas Pharmaceutical Marijuana (MMJ) Sales by Type (2017-2022) & (K Units)
Table 39. Americas Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2017-2022)
Table 40. Americas Pharmaceutical Marijuana (MMJ) Sales by Application (2017-2022) & (K Units)
Table 41. Americas Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2017-2022)
Table 42. APAC Pharmaceutical Marijuana (MMJ) Sales by Region (2017-2022) & (K Units)
Table 43. APAC Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2017-2022)
Table 44. APAC Pharmaceutical Marijuana (MMJ) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2017-2022)
Table 46. APAC Pharmaceutical Marijuana (MMJ) Sales by Type (2017-2022) & (K Units)
Table 47. APAC Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2017-2022)
Table 48. APAC Pharmaceutical Marijuana (MMJ) Sales by Application (2017-2022) & (K Units)
Table 49. APAC Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2017-2022)
Table 50. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2017-2022) & (K Units)
Table 51. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2017-2022)
Table 52. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2017-2022)
Table 54. Europe Pharmaceutical Marijuana (MMJ) Sales by Type (2017-2022) & (K Units)
Table 55. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2017-2022)
Table 56. Europe Pharmaceutical Marijuana (MMJ) Sales by Application (2017-2022) & (K Units)
Table 57. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Pharmaceutical Marijuana (MMJ)
Table 67. Key Market Challenges & Risks of Pharmaceutical Marijuana (MMJ)
Table 68. Key Industry Trends of Pharmaceutical Marijuana (MMJ)
Table 69. Pharmaceutical Marijuana (MMJ) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Pharmaceutical Marijuana (MMJ) Distributors List
Table 72. Pharmaceutical Marijuana (MMJ) Customer List
Table 73. Global Pharmaceutical Marijuana (MMJ) Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Pharmaceutical Marijuana (MMJ) Sales Market Forecast by Region
Table 75. Global Pharmaceutical Marijuana (MMJ) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Pharmaceutical Marijuana (MMJ) Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Pharmaceutical Marijuana (MMJ) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Pharmaceutical Marijuana (MMJ) Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Pharmaceutical Marijuana (MMJ) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Pharmaceutical Marijuana (MMJ) Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Pharmaceutical Marijuana (MMJ) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Pharmaceutical Marijuana (MMJ) Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Pharmaceutical Marijuana (MMJ) Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Pharmaceutical Marijuana (MMJ) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Pharmaceutical Marijuana (MMJ) Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Pharmaceutical Marijuana (MMJ) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Pharmaceutical Marijuana (MMJ) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Canopy Growth Corporation Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 94. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product Offered
Table 95. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Canopy Growth Corporation Main Business
Table 97. Canopy Growth Corporation Latest Developments
Table 98. GW Pharmaceuticals, plc Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 99. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product Offered
Table 100. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. GW Pharmaceuticals, plc Main Business
Table 102. GW Pharmaceuticals, plc Latest Developments
Table 103. Aurora Cannabis, Inc. Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
Table 105. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Aurora Cannabis, Inc. Main Business
Table 107. Aurora Cannabis, Inc. Latest Developments
Table 108. Aphria, Inc. Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 109. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
Table 110. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Aphria, Inc. Main Business
Table 112. Aphria, Inc. Latest Developments
Table 113. MedReleaf Corporation Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 114. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product Offered
Table 115. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. MedReleaf Corporation Main Business
Table 117. MedReleaf Corporation Latest Developments
Table 118. Insys Therapeutics, Inc. Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 119. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
Table 120. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Insys Therapeutics, Inc. Main Business
Table 122. Insys Therapeutics, Inc. Latest Developments
Table 123. CanniMed Therapeutics, Inc. Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 124. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
Table 125. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. CanniMed Therapeutics, Inc. Main Business
Table 127. CanniMed Therapeutics, Inc. Latest Developments
Table 128. Cara Therapeutics, Inc. Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 129. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Offered
Table 130. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Cara Therapeutics, Inc. Main Business
Table 132. Cara Therapeutics, Inc. Latest Developments
Table 133. United Cannabis Corporation Basic Information, Pharmaceutical Marijuana (MMJ) Manufacturing Base, Sales Area and Its Competitors
Table 134. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product Offered
Table 135. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. United Cannabis Corporation Main Business
Table 137. United Cannabis Corporation Latest Developments
List of Figures
Figure 1. Picture of Pharmaceutical Marijuana (MMJ)
Figure 2. Pharmaceutical Marijuana (MMJ) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Marijuana (MMJ) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pharmaceutical Marijuana (MMJ) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pharmaceutical Marijuana (MMJ) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of THC-dominant
Figure 10. Product Picture of CBD-dominant
Figure 11. Product Picture of Balanced THC & CBD
Figure 12. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type in 2021
Figure 13. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2017-2022)
Figure 14. Pharmaceutical Marijuana (MMJ) Consumed in Cancer
Figure 15. Global Pharmaceutical Marijuana (MMJ) Market: Cancer (2017-2022) & (K Units)
Figure 16. Pharmaceutical Marijuana (MMJ) Consumed in Arthritis
Figure 17. Global Pharmaceutical Marijuana (MMJ) Market: Arthritis (2017-2022) & (K Units)
Figure 18. Pharmaceutical Marijuana (MMJ) Consumed in Migraine
Figure 19. Global Pharmaceutical Marijuana (MMJ) Market: Migraine (2017-2022) & (K Units)
Figure 20. Pharmaceutical Marijuana (MMJ) Consumed in Epilepsy
Figure 21. Global Pharmaceutical Marijuana (MMJ) Market: Epilepsy (2017-2022) & (K Units)
Figure 22. Pharmaceutical Marijuana (MMJ) Consumed in Others
Figure 23. Global Pharmaceutical Marijuana (MMJ) Market: Others (2017-2022) & (K Units)
Figure 24. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2017-2022)
Figure 25. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application in 2021
Figure 26. Pharmaceutical Marijuana (MMJ) Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Company in 2021
Figure 28. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Geographic Region in 2021
Figure 30. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2017-2022)
Figure 31. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country/Region in 2021
Figure 32. Americas Pharmaceutical Marijuana (MMJ) Sales 2017-2022 (K Units)
Figure 33. Americas Pharmaceutical Marijuana (MMJ) Revenue 2017-2022 ($ Millions)
Figure 34. APAC Pharmaceutical Marijuana (MMJ) Sales 2017-2022 (K Units)
Figure 35. APAC Pharmaceutical Marijuana (MMJ) Revenue 2017-2022 ($ Millions)
Figure 36. Europe Pharmaceutical Marijuana (MMJ) Sales 2017-2022 (K Units)
Figure 37. Europe Pharmaceutical Marijuana (MMJ) Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue 2017-2022 ($ Millions)
Figure 40. Americas Pharmaceutical Marijuana (MMJ) Sales Market Share by Country in 2021
Figure 41. Americas Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country in 2021
Figure 42. United States Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Pharmaceutical Marijuana (MMJ) Sales Market Share by Region in 2021
Figure 47. APAC Pharmaceutical Marijuana (MMJ) Revenue Market Share by Regions in 2021
Figure 48. China Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Country in 2021
Figure 55. Europe Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country in 2021
Figure 56. Germany Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country in 2021
Figure 63. Egypt Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Pharmaceutical Marijuana (MMJ) Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Pharmaceutical Marijuana (MMJ) in 2021
Figure 69. Manufacturing Process Analysis of Pharmaceutical Marijuana (MMJ)
Figure 70. Industry Chain Structure of Pharmaceutical Marijuana (MMJ)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...